Cargando…
Qishen Yiqi dropping pills improve isoproterenol-induced cardiomyocyte hypertrophy by regulating X-inactive specific transcript (XIST) expression in rats
BACKGROUND: This study aimed to explore the potential mechanism of Qishen Yiqi dropping pills (QYDPs) in the treatment of chronic heart failure (CHF) by regulating the expression of lncRNAs during CHF. METHODS: Differences in the expression of the long non-coding RNA (lncRNA), X-inactive specific tr...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264057/ https://www.ncbi.nlm.nih.gov/pubmed/35813728 http://dx.doi.org/10.21037/jtd-22-606 |
_version_ | 1784742889320873984 |
---|---|
author | Luo, Ying Chen, Jiaxian Chen, Yuewu Su, Yangshen Wu, Xiaoyan Zheng, Wanling Liu, Xianxia Chen, Lei |
author_facet | Luo, Ying Chen, Jiaxian Chen, Yuewu Su, Yangshen Wu, Xiaoyan Zheng, Wanling Liu, Xianxia Chen, Lei |
author_sort | Luo, Ying |
collection | PubMed |
description | BACKGROUND: This study aimed to explore the potential mechanism of Qishen Yiqi dropping pills (QYDPs) in the treatment of chronic heart failure (CHF) by regulating the expression of lncRNAs during CHF. METHODS: Differences in the expression of the long non-coding RNA (lncRNA), X-inactive specific transcript (XIST), in an isoproterenol (ISO)-induced cardiomyocyte hypertrophy model treated with QYDPs was analyzed by reverse transcription quantitative polymerase chain reaction (RT-qPCR). A cell counting kit-8 (CCK8) assay, flow cytometry (FCM), and enzyme linked immunosorbent assay (ELISA) were used to analyze the protective effects of QYDPs on the proliferation rate, apoptosis, myocardial enzyme, oxidative stress, and inflammation of cardiomyocytes, as well as the molecular mechanism of XIST. RESULTS: Our results showed that in the ISO-induced cardiomyocyte hypertrophy model, XIST expression and apoptosis were increased, the cell proliferation rate was decreased, and myocardial enzyme levels increased [i.e., increased lactate dehydrogenase (LDH) and creatine kinase (CK) levels]. Furthermore, cellular oxidative stress [i.e., increased malondialdehyde (MDA) levels and decreased superoxide dismutase (SOD) levels] and inflammatory response [i.e., increased interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α protein secretion] were also promoted. QYDP treatment effectively mitigated the effects of ISO induction. Subsequently, we found that suppressing XIST expression reversed the effect of ISO induction, whereas overexpression (ov) of XIST enhanced the effect of ISO induction. Finally, this study confirmed that QYDP treatment improved the ISO-induced decrease in proliferation, apoptosis, and promotion of oxidative stress and inflammatory response in cardiomyocytes, whereas ov of XIST partially negated the effect of QYDPs. CONCLUSIONS: QYDPs protected H9c2 cells from ISO-induced damage by downregulating XIST expression. |
format | Online Article Text |
id | pubmed-9264057 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-92640572022-07-09 Qishen Yiqi dropping pills improve isoproterenol-induced cardiomyocyte hypertrophy by regulating X-inactive specific transcript (XIST) expression in rats Luo, Ying Chen, Jiaxian Chen, Yuewu Su, Yangshen Wu, Xiaoyan Zheng, Wanling Liu, Xianxia Chen, Lei J Thorac Dis Original Article BACKGROUND: This study aimed to explore the potential mechanism of Qishen Yiqi dropping pills (QYDPs) in the treatment of chronic heart failure (CHF) by regulating the expression of lncRNAs during CHF. METHODS: Differences in the expression of the long non-coding RNA (lncRNA), X-inactive specific transcript (XIST), in an isoproterenol (ISO)-induced cardiomyocyte hypertrophy model treated with QYDPs was analyzed by reverse transcription quantitative polymerase chain reaction (RT-qPCR). A cell counting kit-8 (CCK8) assay, flow cytometry (FCM), and enzyme linked immunosorbent assay (ELISA) were used to analyze the protective effects of QYDPs on the proliferation rate, apoptosis, myocardial enzyme, oxidative stress, and inflammation of cardiomyocytes, as well as the molecular mechanism of XIST. RESULTS: Our results showed that in the ISO-induced cardiomyocyte hypertrophy model, XIST expression and apoptosis were increased, the cell proliferation rate was decreased, and myocardial enzyme levels increased [i.e., increased lactate dehydrogenase (LDH) and creatine kinase (CK) levels]. Furthermore, cellular oxidative stress [i.e., increased malondialdehyde (MDA) levels and decreased superoxide dismutase (SOD) levels] and inflammatory response [i.e., increased interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α protein secretion] were also promoted. QYDP treatment effectively mitigated the effects of ISO induction. Subsequently, we found that suppressing XIST expression reversed the effect of ISO induction, whereas overexpression (ov) of XIST enhanced the effect of ISO induction. Finally, this study confirmed that QYDP treatment improved the ISO-induced decrease in proliferation, apoptosis, and promotion of oxidative stress and inflammatory response in cardiomyocytes, whereas ov of XIST partially negated the effect of QYDPs. CONCLUSIONS: QYDPs protected H9c2 cells from ISO-induced damage by downregulating XIST expression. AME Publishing Company 2022-06 /pmc/articles/PMC9264057/ /pubmed/35813728 http://dx.doi.org/10.21037/jtd-22-606 Text en 2022 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Luo, Ying Chen, Jiaxian Chen, Yuewu Su, Yangshen Wu, Xiaoyan Zheng, Wanling Liu, Xianxia Chen, Lei Qishen Yiqi dropping pills improve isoproterenol-induced cardiomyocyte hypertrophy by regulating X-inactive specific transcript (XIST) expression in rats |
title | Qishen Yiqi dropping pills improve isoproterenol-induced cardiomyocyte hypertrophy by regulating X-inactive specific transcript (XIST) expression in rats |
title_full | Qishen Yiqi dropping pills improve isoproterenol-induced cardiomyocyte hypertrophy by regulating X-inactive specific transcript (XIST) expression in rats |
title_fullStr | Qishen Yiqi dropping pills improve isoproterenol-induced cardiomyocyte hypertrophy by regulating X-inactive specific transcript (XIST) expression in rats |
title_full_unstemmed | Qishen Yiqi dropping pills improve isoproterenol-induced cardiomyocyte hypertrophy by regulating X-inactive specific transcript (XIST) expression in rats |
title_short | Qishen Yiqi dropping pills improve isoproterenol-induced cardiomyocyte hypertrophy by regulating X-inactive specific transcript (XIST) expression in rats |
title_sort | qishen yiqi dropping pills improve isoproterenol-induced cardiomyocyte hypertrophy by regulating x-inactive specific transcript (xist) expression in rats |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264057/ https://www.ncbi.nlm.nih.gov/pubmed/35813728 http://dx.doi.org/10.21037/jtd-22-606 |
work_keys_str_mv | AT luoying qishenyiqidroppingpillsimproveisoproterenolinducedcardiomyocytehypertrophybyregulatingxinactivespecifictranscriptxistexpressioninrats AT chenjiaxian qishenyiqidroppingpillsimproveisoproterenolinducedcardiomyocytehypertrophybyregulatingxinactivespecifictranscriptxistexpressioninrats AT chenyuewu qishenyiqidroppingpillsimproveisoproterenolinducedcardiomyocytehypertrophybyregulatingxinactivespecifictranscriptxistexpressioninrats AT suyangshen qishenyiqidroppingpillsimproveisoproterenolinducedcardiomyocytehypertrophybyregulatingxinactivespecifictranscriptxistexpressioninrats AT wuxiaoyan qishenyiqidroppingpillsimproveisoproterenolinducedcardiomyocytehypertrophybyregulatingxinactivespecifictranscriptxistexpressioninrats AT zhengwanling qishenyiqidroppingpillsimproveisoproterenolinducedcardiomyocytehypertrophybyregulatingxinactivespecifictranscriptxistexpressioninrats AT liuxianxia qishenyiqidroppingpillsimproveisoproterenolinducedcardiomyocytehypertrophybyregulatingxinactivespecifictranscriptxistexpressioninrats AT chenlei qishenyiqidroppingpillsimproveisoproterenolinducedcardiomyocytehypertrophybyregulatingxinactivespecifictranscriptxistexpressioninrats |